Treatment
Treatment clinical trials
We’re tracking 8,580 recruiting studies that include Treatment, each written for real people, not researchers, below.
Recruiting studies
- NCT06456073RecruitingPhase 1
Cell therapy for chronic anal fissures
This trial tests a new treatment made from special cells (called E-CEL UVEC) for people with long-lasting anal fissures that haven't healed with standard treatments. The goal is to see if this cell-based therapy can reduce pain and help the fissure heal.
New York, New YorkAges 18 years+ - NCT06526767Recruiting
Vibrating capsule for chronic constipation dose comparison
This study tests three different doses of a vibrating capsule (Vibrabot) to see which works best for relieving chronic constipation. If you have had constipation for at least 6 months and meet the Rome IV criteria, you may be able to join.
Beijing, Beijing MunicipalityAges 18–85 - NCT05828719Recruiting
Compare heart stent treatment vs medicines for weak heart function
This study looks at whether opening blocked heart arteries with a stent (a PCI procedure) works better than staying on heart medicines for people with weakened pumping function and certain types of heart failure. It may help patients by testing which approach best improves outcomes over time.
SeoulAges 19 years+ - NCT06527482Recruiting
Using your own bone and cartilage to repair ankle damage
This trial tests a surgery that takes a small piece of bone and cartilage from your knee and transplants it to a damaged area in your ankle. It may help people with severe ankle cartilage injuries that haven't gotten better with other treatments.
BeijingAges 18–60 - NCT07226388Enrolling by invitation
Pyrocarbon hemiarthroplasty vs total shoulder replacement for osteoarthritis
This study compares two types of shoulder replacement surgery for people with osteoarthritis: one that replaces only the ball of the joint (hemiarthroplasty with a pyrocarbon ball) and one that replaces both the ball and socket (total shoulder arthroplasty). The goal is to see which option works better for people with this condition.
St Louis, MissouriAges 40–65 - NCT06968494Recruiting
Implantable device to preserve erections after prostate surgery
This trial tests a new implantable device designed to help men keep their erections after nerve-sparing prostate surgery. If you are having surgery for early-stage prostate cancer and have good erectile function now, this device might help you maintain it.
Baltimore, MarylandAges 30–75 - NCT07223125RecruitingPhase 1
Study of JNJ-89862175 for Advanced Solid Tumors
This trial tests a new drug called JNJ-89862175 for people with certain advanced solid tumors, including lung adenocarcinoma, kidney cancer, ovarian cancer, and uterine cancer. The goal is to see if this treatment is safe and effective.
Orlando, FloridaAges 18 years+ - NCT05260619RecruitingPhase 2
Lenalidomide after response for primary brain lymphoma
This trial studies lenalidomide taken after your first treatment has worked for primary central nervous system lymphoma (PCNSL). It aims to help keep the lymphoma from coming back by testing lenalidomide as ongoing “maintenance” treatment.
Seongnam-si, Please SelectAges 19 years+ - NCT07220278Recruiting
HIV treatment support study in Malawi
This study tests a program to help people living with HIV who have missed their recent treatment appointment get back on track. It aims to find better ways to support ongoing treatment.
LilongweAges 15 years+ - NCT07219992Recruiting
Parent-led treatment for teens with anxiety
This study tests a program that helps parents learn ways to support their teenager who has an anxiety disorder, like social anxiety or panic attacks. The goal is to see if this parent-based approach can reduce the teen's anxiety without the teen needing to attend therapy sessions.
New Haven, ConnecticutAges 14–17 - NCT04924998Recruiting
Study for AL-CM treatment in adults at one hospital
This study is looking at a treatment approach for people diagnosed with AL-CM at a specific hospital. It may help researchers understand whether the treatment is safe and effective for patients like you.
Hangzhou, ZhejiangAges 18–80 - NCT06531278RecruitingPhase 2
Adebelimab plus chemo for first-line pancreatic cancer with liver spread
This trial tests a combination of immunotherapy (adebelimab) and chemotherapy drugs (irinotecan liposome, oxaliplatin, fluorouracil, and calcium folinate) as a first treatment for pancreatic cancer that has spread to the liver. The goal is to see if this combination is safe and effective.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06846359Recruiting
Hypnotherapy for Upper Gut Symptoms
This study tests whether hypnotherapy sessions, delivered through a smartphone app, can help relieve upper digestive symptoms like nausea, bloating, and indigestion. It's for people whose symptoms are not caused by a known disease and who have already had normal stomach-emptying tests.
Rochester, MinnesotaAges 18 years+ - NCT07217405RecruitingPhase 4
Radiation or steroid shot for hand osteoarthritis pain
This trial compares low-dose radiation therapy to a corticosteroid injection to see which works better for hand osteoarthritis pain. It's for people 50 and older with moderate to severe hand OA who have significant pain when using their hand.
Rochester, MinnesotaAges 50 years+ - NCT05514015RecruitingPhase 4
Rituximab with steroids or rituximab alone for membranous kidney disease
This trial studies how well rituximab works in primary membranous nephropathy (a kidney condition) either by itself or with corticosteroids (steroids). It aims to see which approach controls protein leakage in the urine and protects kidney function.
Guangzhou, GuangdongAges 18–75 - NCT06802042Recruiting
Probiotic for constipation in pregnancy
This trial tests if a probiotic called Lactobacillus can help relieve constipation in pregnant women and improve gut health. It compares the probiotic to a placebo to see if it is safe and effective.
Beijing, Beijing MunicipalityAges 18–40 - NCT06531434RecruitingPhase 1/Phase 2
Best treatment plan for advanced esophageal cancer
This trial is for people with T4 esophageal cancer, where the tumor has spread to nearby organs. It aims to find the best treatment approach to improve outcomes.
Tainan, TaiwanAges 18–70 - NCT06531499RecruitingPhase 1
Study of a radioactive drug for advanced prostate cancer
This trial tests an extended treatment with a radioactive drug (177Lu-PSMA-617) to see how the body handles it, how safe it is, and how well it works. It is for men with metastatic castration-resistant prostate cancer who have not had chemotherapy yet.
Los Angeles, CaliforniaAges 18–100 - NCT06569056RecruitingPhase 3
HRS-8427 for complicated urinary tract infections
This trial tests a new antibiotic, HRS-8427, for people with complicated urinary tract infections (UTIs) or kidney infections. If you qualify, you would receive the study drug through an IV while in the hospital.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07214233Recruiting
Youth empowerment and safety study for LGBTQ+ teens
This trial tests a program to help sexual and gender minority youth (ages 12-17) who have been involved with systems like juvenile justice or mental health services and have had thoughts of self-harm. It includes a caregiver to support the teen.
Cleveland, OhioAges 12–17 - NCT06839209Recruiting
Add-on TOXCLEAN for recurrent C. difficile diarrhea
This trial tests an add-on treatment called TOXCLEAN for people with repeat C. difficile diarrhea. It aims to see if adding TOXCLEAN to standard antibiotics helps more than antibiotics alone.
RomaAges 18 years+ - NCT05776342Recruiting
Markers study for treatment response in pancreatic cancer
This study looks at tumor “markers” (tests on cancer tissue or related information) to understand how you may respond to first-line treatment for pancreatic cancer. Your results may help doctors better predict which treatments work best for different people.
BesançonAges 18 years+ - NCT06848166RecruitingEarly Phase 1
Middle meningeal artery embolization for resistant chronic migraine
This study tests a procedure called 'middle meningeal artery embolization' using a special glue-like material (SQUID) to treat chronic migraine that hasn't responded to other treatments. The goal is to see if blocking blood flow to the membrane around the brain can reduce migraine attacks.
Bishkek, BishkekAges 35–59 - NCT04871035Recruiting
Compare immunoadsorption vs plasma exchange for Guillain-Barré
This study tests whether immunoadsorption works as well as plasma exchange to improve symptoms in people with Guillain-Barré syndrome. The goal is to find which treatment helps recovery and is safer for patients.
Ulm, Baden-WurttembergAges 18 years+
Common questions
- Are there clinical trials studying Treatment?
- Yes. Clin2 currently lists 8,580 recruiting studies that include Treatment, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.